Aurinia Pharmaceuticals, Inc. (AUPH)
15.45
-0.45
(-2.83%)
USD |
NASDAQ |
May 21, 16:00
15.45
0.00 (0.00%)
After-Hours: 19:59
Aurinia Pharmaceuticals Research and Development Expense (TTM) : 34.23M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Xenon Pharmaceuticals, Inc. | 325.78M |
| Edesa Biotech, Inc. | 6.056M |
| ProMIS Neurosciences, Inc. | 34.89M |
| Medicus Pharma Ltd. | 6.093M |
| Kiniksa Pharmaceuticals International Plc | 104.70M |